The expression levels of PPase have been suggested as a potential biomarker of various cancers, and their prognostic value has been evaluated in patients suffering from lung cancer, colorectal cancer, and hyperthyroidism [3]. This evidence concerns the gene PPA1 and lung carcinoma.